Oral Infectious Disease: Virulence and Host Determinants

口腔传染病:毒力和宿主决定因素

基本信息

  • 批准号:
    6858280
  • 负责人:
  • 金额:
    $ 10.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-01 至 2006-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: Streptococcus mutans is part of the normal oral flora, and promotes caries under opportunistic conditions. Knowledge of interacting factors between host and S. mutans that contribute to caries is still primitive. Specific Aim 1: Ascertain the influence of specific salivary secretory constituents in the development of caries. We will study three salivary constituents, high molecular weight salivary mucin (Muc19), low molecular weight salivary mucin (Muc10), and salivary amylase (Amy 1). All three genes have been identified in the mouse genome. We will produce knockout mice for direct evaluation in caries experiments. We will also produce double and triple knockout animals to test for additive, synergistic, or possibly even competitive effects on caries. Specific Aim 2: Evaluate S. mutans genes for their role as virulence factors associated with infection of the oral cavity and subsequent caries development. We will focus on: i) glucosyltransferase B/C (gtfB/C) and gtfB/C/D; 2) Antigen I/II (Ag I/II); and 3) a putative fibronectin/fibrinogen-binding protein gene that is up-regulated at pH 5 (fbp, Smu. 1449). Ag I/II and fbp will be studied as single mutations, and in the genetic backgrounds, gtfB/C and gtfB/C/D, to help elucidate their roles in the infection process. Binding profiles to hydroxyapatite beads, coated with whole saliva, parotid saliva, submandibular/sublingual saliva, Muc l9, Muc 10 or amylase will be determined. Infectious mutant strains will be tested for induction of caries. We will also perform cDNA microarray analyses of mutant versus wild-type strains to determine whether Fbp functions in the up- or down-regulation of cell-wall associated proteins. We will determine the effects of saliva on gene expression in S. mutans and how the cells respond in the absence of specific genes, gtfs, fbp and AgI/II. Specific Aim 3: Determine the interaction between an S. mutans virulence factor and a specific salivary secretory constituent in the development of caries. As we elucidate the roles of salivary constituents and S. mutans genes in caries, we will then determine contrasting or additive/cooperative interactions between host and bacterial determinates. These studies will delineate specific bacterial and host determinants that function in caries. Future studies can then focus on molecular mechanisms of host-pathogen interactions. Results may indicate important therapeutic targets to treat patients at high risk for caries (i.e., patients with xerostomia).
描述:变形链球菌是正常口腔菌群的一部分,在条件条件下促进龋齿。宿主和变形链球菌之间的相互作用因素导致龋齿的知识仍然是原始的。具体目标1:确定特定唾液分泌成分在龋齿发展中的影响。我们将研究三种唾液成分,高分子量唾液粘蛋白(Muc19),低分子量唾液粘蛋白(Muc10)和唾液淀粉酶(Amy 1)。这三个基因都已在小鼠基因组中被鉴定出来。我们将生产基因敲除小鼠,用于龋齿实验的直接评估。我们还将生产双重和三重基因敲除动物,以测试对龋齿的附加、协同甚至可能的竞争效应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID JOHN CULP其他文献

DAVID JOHN CULP的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID JOHN CULP', 18)}}的其他基金

Oral Mucins as a Diagnostic Indicator and Therapeutic Treatment for Xerostomia
口腔粘蛋白作为口干症的诊断指标和治疗方法
  • 批准号:
    8127791
  • 财政年份:
    2010
  • 资助金额:
    $ 10.63万
  • 项目类别:
Oral Mucins as a Diagnostic Indicator and Therapeutic Treatment for Xerostomia
口腔粘蛋白作为口干症的诊断指标和治疗方法
  • 批准号:
    7772225
  • 财政年份:
    2010
  • 资助金额:
    $ 10.63万
  • 项目类别:
Oral Infectious Disease: Virulence and Host Determinants
口腔传染病:毒力和宿主决定因素
  • 批准号:
    7480293
  • 财政年份:
    2005
  • 资助金额:
    $ 10.63万
  • 项目类别:
Oral Infectious Disease: Virulence and Host Determinants
口腔传染病:毒力和宿主决定因素
  • 批准号:
    7115848
  • 财政年份:
    2005
  • 资助金额:
    $ 10.63万
  • 项目类别:
Oral Infectious Disease: Virulence and Host Determinants
口腔传染病:毒力和宿主决定因素
  • 批准号:
    7277846
  • 财政年份:
    2005
  • 资助金额:
    $ 10.63万
  • 项目类别:
Oral Infectious Disease: Virulence and Host Determinants
口腔传染病:毒力和宿主决定因素
  • 批准号:
    7175263
  • 财政年份:
    2005
  • 资助金额:
    $ 10.63万
  • 项目类别:
Oral Infectious Disease: Virulence and Host Determinants
口腔传染病:毒力和宿主决定因素
  • 批准号:
    7661346
  • 财政年份:
    2005
  • 资助金额:
    $ 10.63万
  • 项目类别:
SALIVARY MUCOUS CELL GENE EXPRESSION
唾液粘液细胞基因表达
  • 批准号:
    7234789
  • 财政年份:
    2003
  • 资助金额:
    $ 10.63万
  • 项目类别:
SALIVARY MUCOUS CELL GENE EXPRESSION
唾液粘液细胞基因表达
  • 批准号:
    7051412
  • 财政年份:
    2003
  • 资助金额:
    $ 10.63万
  • 项目类别:
SALIVARY MUCOUS CELL GENE EXPRESSION
唾液粘液细胞基因表达
  • 批准号:
    6630223
  • 财政年份:
    2003
  • 资助金额:
    $ 10.63万
  • 项目类别:

相似海外基金

Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
  • 批准号:
    10585773
  • 财政年份:
    2023
  • 资助金额:
    $ 10.63万
  • 项目类别:
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
1 型糖尿病前期外分泌胰腺功能障碍的自然史和机制
  • 批准号:
    10591260
  • 财政年份:
    2023
  • 资助金额:
    $ 10.63万
  • 项目类别:
Advancing the Clinical Translation of Cyst Fluid Assays for Early Detection of Pancreatic Cancer
推进囊肿液检测的临床转化以早期检测胰腺癌
  • 批准号:
    10639705
  • 财政年份:
    2023
  • 资助金额:
    $ 10.63万
  • 项目类别:
High-definition Endoscopic Ultrasound Navigation for Targeted Dual Neuromodulation Therapy
用于靶向双重神经调节治疗的高清内窥镜超声导航
  • 批准号:
    10817376
  • 财政年份:
    2023
  • 资助金额:
    $ 10.63万
  • 项目类别:
Molecular mechanisms of oral deficiencies in Down syndrome
唐氏综合症口腔缺陷的分子机制
  • 批准号:
    10658410
  • 财政年份:
    2023
  • 资助金额:
    $ 10.63万
  • 项目类别:
Attenuation of Multiorgan Dysfunction after Shock in the Aged
老年人休克后多器官功能障碍的减弱
  • 批准号:
    10719678
  • 财政年份:
    2023
  • 资助金额:
    $ 10.63万
  • 项目类别:
Alternative Orosensory Signals Contributing to Sugar Taste
影响糖味的替代嗅觉信号
  • 批准号:
    10827641
  • 财政年份:
    2023
  • 资助金额:
    $ 10.63万
  • 项目类别:
Self-regulation of Lipases by Changes to Quaternary Structure
通过四级结构的变化进行脂肪酶的自我调节
  • 批准号:
    10429286
  • 财政年份:
    2022
  • 资助金额:
    $ 10.63万
  • 项目类别:
Self-regulation of Lipases by Changes to Quaternary Structure
通过四级结构的变化进行脂肪酶的自我调节
  • 批准号:
    10703368
  • 财政年份:
    2022
  • 资助金额:
    $ 10.63万
  • 项目类别:
A novel highly stable pancreatic enzyme replacement therapy to improve outcomes for patients with pancreatic insufficiency.
一种新型高度稳定的胰酶替代疗法,可改善胰腺功能不全患者的预后。
  • 批准号:
    10543210
  • 财政年份:
    2022
  • 资助金额:
    $ 10.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了